Skip to main content

Published locations for T-VEC plus pembrolizumab yields promising response rate in phase 2 sarcoma study

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. T-VEC plus pembrolizumab yields promising response rate in phase 2 sarcoma study

User login

  • Reset your password
  • /content/t-vec-plus-pembrolizumab-yields-promising-response-rate-phase-2-sarcoma-study
  • /oncologypractice/article/216067/sarcoma-gist/t-vec-plus-pembrolizumab-yields-promising-response-rate
  • /hematology-oncology/article/216067/sarcoma-gist/t-vec-plus-pembrolizumab-yields-promising-response